Upstate Active Clinical Trials
Study Title:Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction (CHARM)
What is the purpose of the study?To determine if BIIB093 improves functional outcome when compared with placebo in participants with Large Hemispheric Infarction (LHI)
Upstate Institutional Review Board (IRB) Number:1243116
Study Phase:Phase 3
Patient Age Group:Adults
Principal Investigator:Julius Gene S Latorre
What is involved if I participate?
- How long is the study?
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
- What tests and procedures are involved?
ECG, neuroimaging, blood tests, NIHSS, mRS
Where will the study take place?Upstate Hospital
Who can I contact for more information?
Name: Lena F Deb